Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2014
The investigators will test the central hypothesis that DFO treatment after SAH may improve cerebrovascular regulation, mitigate ischemic neural injury, and serve as an effective neuroprotectant against delayed ischemic injury after SAH.
Epistemonikos ID: 077f473630e1342b46a0dba97a008095466ff3a3
First added on: May 12, 2024